Cytomegalovirus infection trials in United States

In United States 23 Also abroad 66

23 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
CMV CTLs in Neonates With CMV Infection
Where
Columbus, Los Angeles, St Louis, Vallhala
Age
0 days to 21 days
People
23
Run by
New York Medical College
See details and how to joinNCT05564598
Phase 2Taking people
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Where
Baltimore, Columbus, Indianapolis, Los Angeles, Milwaukee, Philadelphia, San Francisco, St Louis, Valhalla
Age
1 month to 79 years
People
20
Run by
New York Medical College
See details and how to joinNCT03266640
Phase 2Taking people
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Where
Atlanta, Boston, Duarte
Age
18 years to 75 years
People
216
Run by
City of Hope Medical Center
See details and how to joinNCT06059391
Phase 1/2Taking people
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
Where
Duarte
Age
1 year to 21 years
People
80
Run by
City of Hope Medical Center
See details and how to joinNCT03354728
Phase 3Taking people
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Where
Aurora, Baltimore, Birmingham, Columbus, Dallas, Detroit, Fort Worth, Grand Rapids, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jacksonville, Kansas City, Louisville, Madison, Memphis, Miami, Nashville, New Orleans, Oakland, Oklahoma City, Philadelphia, Richmond, Salt Lake City, San Antonio, San Francisco, St Louis, Valhalla, Wilmington
Age
2 years to 18 years
People
105
Run by
Children's Oncology Group
See details and how to joinNCT05711667
Phase 4Not yet taking people in United States
Letermovir for R+ Study
Where
Madison
Age
18 years and over
People
146
Run by
University of Wisconsin, Madison
See details and how to joinNCT07706166
Phase 3Taking people
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
Where
Milwaukee, Valhalla
Age
1 day to 30 years
People
138
Run by
New York Medical College
See details and how to joinNCT07225972
Phase 2Not yet taking people in United States
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II
Where
Los Angeles, San Francisco
Age
18 years and over
People
117 worldwide
Run by
University of California, San Francisco
See details and how to joinNCT07513623
Phase 4Enrolling by invitation
CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients
Where
Pittsburgh
Age
18 years to 75 years
People
45
Run by
Fernanda P Silveira, MD, MS
See details and how to joinNCT07009548
Phase 2Taking people
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Where
Houston
Age
18 years and over
People
28
Run by
The Methodist Hospital Research Institute
See details and how to joinNCT07383649
Phase 2Taking people
Study Evaluating the Efficacy and Safety of Artesunate
Where
Boston, Rochester
Age
18 years and over
People
90 worldwide
Run by
Amivas Inc.
See details and how to joinNCT06853184
Phase 1Taking people
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Where
New York
Age
3 months to 26 years
People
18
Run by
Monica Bhatia
See details and how to joinNCT06926894
Phase 1/2Enrolling by invitation
Anti-viral T-cell Therapy by Gamma Capture
Where
Pittsburgh
Age
1 month to 65 years
People
25
Run by
Paul Szabolcs
See details and how to joinNCT06027879
No phaseTaking people
Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Where
Houston
Age
18 years and over
People
100 worldwide
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT05234723
Phase 3Taking people
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Where
Madison
Age
18 years and over
People
90
Run by
University of Wisconsin, Madison
See details and how to joinNCT06407232
Phase 1Taking people
R-MVST Cells for Treatment of Viral Infections
Where
New York
Age
18 years and over
People
36
Run by
Columbia University
See details and how to joinNCT05183490
Phase 3Taking people
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Where
Chicago, Cincinnati, Fort Worth, Houston, Omaha, St. Petersburg, Wilmington
Age
Up to 17 years
People
80 worldwide
Run by
Takeda
See details and how to joinNCT05319353 · EU 2023-508988-73-00
Phase 4Not yet taking people in United States
Letermovir vs Valganciclovir in CMV R+ Kidney Transplant
Where
San Antonio
Age
18 years and over
People
300
Run by
Elisabeth Kincaide
See details and how to joinNCT07571135
No phaseTaking people
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
Where
Miami
Age
18 years to 75 years
People
100
Run by
University of Miami
See details and how to joinNCT06494033
Phase 4Taking people
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Where
Boston, Dallas
Age
18 years to 75 years
People
80
Run by
Camille N. Kotton, MD
See details and how to joinNCT06958796
Early phase 1Taking people
T Cell Therapy of Opportunistic Cytomegalovirus Infection
Where
Cleveland
Age
3 months and over
People
20
Run by
Mari Dallas
See details and how to joinNCT02982902
Phase 1/2Taking people
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Where
Palo Alto
Age
1 month to 65 years
People
25
Run by
Jessie L. Alexander
See details and how to joinNCT06909110
No phaseTaking people
Long-Term Outcomes of Children With Congenital CMV in New York State
Where
Stony Brook
Age
0 days to 1 year
People
1,000
Run by
Stony Brook University
See details and how to joinNCT06226558